The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 121, Issue 2, Pages 476-483
Publisher
American Society for Clinical Investigation
Online
2011-02-01
DOI
10.1172/jci45364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- “Frontal” Behaviors Before the Diagnosis of Huntington’s Disease and Their Relationship to Markers of Disease Progression: Evidence of Early Lack of Awareness
- (2014) Kevin Duff et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Hypothalamic and Neuroendocrine Changes in Huntingtons Disease
- (2012) Sofia Hult et al. CURRENT DRUG TARGETS
- Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntingtons Disease - from Clinical Features to the Bench
- (2012) Tatiana R. Rosenstock et al. CURRENT DRUG TARGETS
- Brain networks in Huntington disease
- (2011) David Eidelberg et al. JOURNAL OF CLINICAL INVESTIGATION
- Oligonucleotide therapeutic approaches for Huntington disease
- (2011) Dinah W.Y. Sah et al. JOURNAL OF CLINICAL INVESTIGATION
- Energy deficit in Huntington disease: why it matters
- (2011) Fanny Mochel et al. JOURNAL OF CLINICAL INVESTIGATION
- Metabolic analysis of 13C-labeled pyruvate for noninvasive assessment of mitochondrial function
- (2010) I-Chien Wu et al. Annals of the New York Academy of Sciences
- Clearance of Mutant Proteins as a Therapeutic Target in Neurodegenerative Diseases
- (2010) Dimitri Krainc ARCHIVES OF NEUROLOGY
- A Randomized, Placebo-Controlled Trial of Latrepirdine in Huntington Disease
- (2010) Karl Kieburtz ARCHIVES OF NEUROLOGY
- Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington’s disease
- (2010) Doris C. V. Thu et al. BRAIN
- Striatal and white matter predictors of estimated diagnosis for Huntington disease
- (2010) Jane S. Paulsen et al. BRAIN RESEARCH BULLETIN
- Dopamine and Glutamate in Huntington's Disease: A Balancing Act
- (2010) Véronique M. André et al. CNS Neuroscience & Therapeutics
- Advances in the Pharmacological Management of Huntingtonʼs Disease
- (2010) Samuel Frank et al. DRUGS
- Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease
- (2010) Stephen J. McConoughey et al. EMBO Molecular Medicine
- Lack of efficacy of NMDA receptor-NR2B selective antagonists in the R6/2 model of Huntington disease
- (2010) Sara J. Tallaksen-Greene et al. EXPERIMENTAL NEUROLOGY
- Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease
- (2010) Allison D. Ebert et al. EXPERIMENTAL NEUROLOGY
- Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
- (2010) Daniel J. Ho et al. EXPERIMENTAL NEUROLOGY
- Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma
- (2010) Ming-Chang Chiang et al. HUMAN MOLECULAR GENETICS
- An ovine transgenic Huntington's disease model
- (2010) J. C. Jacobsen et al. HUMAN MOLECULAR GENETICS
- Mitochondrial functional alterations in relation to pathophysiology of Huntington’s disease
- (2010) Mritunjay Pandey et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Partial Depletion of CREB-Binding Protein Reduces Life Expectancy in a Mouse Model of Huntington Disease
- (2010) Alexandra M. Klevytska et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo
- (2010) K. Van Laere et al. JOURNAL OF NUCLEAR MEDICINE
- Chronic Suppression of Phosphodiesterase 10A Alters Striatal Expression of Genes Responsible for Neurotransmitter Synthesis, Neurotransmission, and Signaling Pathways Implicated in Huntington's Disease
- (2010) R. J. Kleiman et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Uncovering the true prevalence of Huntington's disease
- (2010) Laura Spinney LANCET NEUROLOGY
- Tetrabenazine is neuroprotective in Huntington's disease mice
- (2010) Hongyu Wang et al. Molecular Neurodegeneration
- Autophagy gone awry in neurodegenerative diseases
- (2010) Esther Wong et al. NATURE NEUROSCIENCE
- Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease
- (2010) Marta Martinez-Vicente et al. NATURE NEUROSCIENCE
- Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
- (2010) Harald Hampel et al. NATURE REVIEWS DRUG DISCOVERY
- Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease
- (2010) Kun Huang et al. NEUROBIOLOGY OF DISEASE
- The role of REST in transcriptional and epigenetic dysregulation in Huntington's disease
- (2010) Noel J. Buckley et al. NEUROBIOLOGY OF DISEASE
- Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice
- (2010) Austen J. Milnerwood et al. NEURON
- Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
- (2010) Chiara Zuccato et al. PHYSIOLOGICAL REVIEWS
- The Role of Sirtuins in the Control of Metabolic Homeostasis
- (2009) Jiujiu Yu et al. Annals of the New York Academy of Sciences
- Farnesyltransferase inhibitors-induced autophagy: Alternative mechanisms?
- (2009) Jingxuan Pan et al. Autophagy
- Abnormal Motor Cortex Excitability in Preclinical and Very Early Huntington's Disease
- (2009) Sven Schippling et al. BIOLOGICAL PSYCHIATRY
- Microglial CB2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity
- (2009) Javier Palazuelos et al. BRAIN
- Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington’s disease
- (2009) Carmela Giampà et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Huntington's disease: The current state of research with peripheral tissues
- (2009) Jenny Sassone et al. EXPERIMENTAL NEUROLOGY
- Impaired PGC-1α function in muscle in Huntington's disease
- (2009) Rajnish K. Chaturvedi et al. HUMAN MOLECULAR GENETICS
- Combination therapy with Coenzyme Q10and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases
- (2009) Lichuan Yang et al. JOURNAL OF NEUROCHEMISTRY
- Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum
- (2009) Andrea N. Ortiz et al. JOURNAL OF NEUROCHEMISTRY
- Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
- (2009) P. R. Joshi et al. JOURNAL OF NEUROSCIENCE
- Alterations in Cortical Excitation and Inhibition in Genetic Mouse Models of Huntington's Disease
- (2009) D. M. Cummings et al. JOURNAL OF NEUROSCIENCE
- In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease
- (2009) M. Y. Heng et al. JOURNAL OF NEUROSCIENCE
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data
- (2009) Sarah J Tabrizi et al. LANCET NEUROLOGY
- The gene coding for PGC-1α modifies age at onset in Huntington's Disease
- (2009) Patrick Weydt et al. Molecular Neurodegeneration
- Motor abnormalities in premanifest persons with Huntington's disease: The PREDICT-HD study
- (2009) Kevin M. Biglan et al. MOVEMENT DISORDERS
- Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
- (2009) Shu-ichi Okamoto et al. NATURE MEDICINE
- Y-27632 improves rotarod performance and reduces huntingtin levels in R6/2 mice
- (2009) Mei Li et al. NEUROBIOLOGY OF DISEASE
- Cortical dopamine dysfunction in symptomatic and premanifest Huntington's disease gene carriers
- (2009) Nicola Pavese et al. NEUROBIOLOGY OF DISEASE
- Magnetic resonance imaging of Huntington's disease: preparing for clinical trials
- (2009) S. Klöppel et al. NEUROSCIENCE
- Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease
- (2009) Dénes Zádori et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Changes in striatal dopamine D2 receptor binding in pre-clinical Huntington’s disease
- (2008) J.C.H. van Oostrom et al. EUROPEAN JOURNAL OF NEUROLOGY
- Huntington’s disease: revisiting the aggregation hypothesis in polyglutamine neurodegenerative diseases
- (2008) Ray Truant et al. FEBS Journal
- Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells
- (2008) Rodrigo A. Quintanilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington’s disease phenotypes in mice
- (2008) Kusumika Gharami et al. JOURNAL OF NEUROCHEMISTRY
- Dysregulation of Gene Expression in Primary Neuron Models of Huntington's Disease Shows That Polyglutamine-Related Effects on the Striatal Transcriptome May Not Be Dependent on Brain Circuitry
- (2008) H. Runne et al. JOURNAL OF NEUROSCIENCE
- Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice
- (2008) M. Gray et al. JOURNAL OF NEUROSCIENCE
- Striatal volume differences between non-human and human primates
- (2008) Dali Yin et al. JOURNAL OF NEUROSCIENCE METHODS
- CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice
- (2008) Barbara L. Apostol et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
- (2008) Andrea Williams et al. Nature Chemical Biology
- Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
- (2008) Zena DeMarch et al. NEUROBIOLOGY OF DISEASE
- Rodent genetic models of Huntington disease
- (2008) Mary Y. Heng et al. NEUROBIOLOGY OF DISEASE
- Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouse
- (2008) B.R. Miller et al. NEUROSCIENCE
- The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice
- (2008) E. A. Thomas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The effects of modafinil on mood and cognition in Huntington’s disease
- (2008) Andrew D. Blackwell et al. PSYCHOPHARMACOLOGY
- Positron emission tomography analysis of [11C]KW‐6002 binding to human and rat adenosine A2Areceptors in the brain
- (2008) D.J. Brooks et al. SYNAPSE
- Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat
- (2007) H H Ruocco et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Detection of Huntington's disease decades before diagnosis: the Predict-HD study
- (2007) J S Paulsen et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now